Simcere Pharmaceutical (SCR) IPO Opens Higher
Tweet Send to a Friend
The IPO for Simcere Pharmaceutical Group (NYSE: SCR) is open for trading. The stock is trading at $14.74 after ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE